FDA Drug Application (085827) for HYDRALAZINE AND HYDROCHLOROTHIAZIDE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number085827
Product Number001
FormTABLET;ORAL
Dosage25MG;15MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDRALAZINE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by WATSON LABS